Brief: Factor Therapeutics Updates On Share Purchase Agreement To Acquire Powerlime
July 26 (Reuters) - Factor Therapeutics Ltd FTT.AX :
* CONDITIONAL SHARE PURCHASE AGREEMENT TO ACQUIRE POWERLIME
* NOW ENTERED SHARE PURCHASE AGREEMENT WITH POWERLIME,
POWERLIME
SHAREHOLDERS
* DEAL TO BUY ALL ISSUED SHARES IN POWERLIME
* PROPOSES TO ISSUE 187.5 MILLION SHARES TO POWERLIME'S
SHAREHOLDERS AT A$0.004 PER SHARE
* FOLLOWING CLOSE OF DEAL, CO WILL UNDERTAKE A$4M CAPITAL
RAISE AT
A$0.004
Source text for Eikon: ID:nASX8VdP2k
Further company coverage: FTT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InVert Graphite
See all newsBrief: Invert Graphite Says Rapidgraphite Acquisition Now Unconditional
Australia's InVert Graphite rises on acquiring graphite processing technology provider
Brief: Invert Graphite Seeks Trading Halt
Brief: Invert Graphite Says CEO Andrew Lawson Transitions To Managing Director
Brief: Invert Graphite Says David Brookes Has Resigned As Non-Executive Chair